Unknown

Dataset Information

0

Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma.


ABSTRACT:

Background

Down syndrome (DS) is the most common known aneuploidy, caused by an extra copy of all or part of chromosome 21. Fetal-specific epigenetic markers have been investigated for non-invasive prenatal detection of fetal DS. The phosphodiesterases gene, PDE9A, located on chromosome 21q22.3, is completely methylated in blood (M-PDE9A) and unmethylated in the placenta (U-PDE9A). Therefore, we estimated the accuracy of non-invasive fetal DS detection during the first trimester of pregnancy using this tissue-specific epigenetic characteristic of PDE9A.

Methodology/principal findings

A nested, case-control study was conducted using maternal plasma samples collected from 108 pregnant women carrying 18 DS and 90 normal fetuses (each case was matched with 5 controls according to gestational weeks at blood sampling). All pregnancies were singletons at or before 12 weeks of gestation between October 2008 and May 2009. The maternal plasma levels of M-PDE9A and U-PDE9A were measured by quantitative methylation-specific polymerase chain reaction. M-PDE9A and U-PDE9A levels were obtained in all samples and did not differ between male and female fetuses. M-PDE9A levels did not differ between the DS cases and controls (1854.3 vs 2004.5 copies/mL; P?=?0.928). U-PDE9A levels were significantly elevated in women with DS fetuses compared with controls (356.8 vs 194.7 copies/mL, P<0.001). The sensitivities of U-PDE9A level and the unmethylation index of PDE9A for non-invasive fetal DS detection were 77.8% and 83.3%, respectively, with a 5% false-positive rate. In the risk assessment for fetal DS, the adjusted odds ratios of U-PDE9A level and UI were 46.2 [95% confidence interval: 7.8-151.6] and 63.7 [95% confidence interval: 23.2-206.7], respectively.

Conclusions

Our findings suggest that U-PDE9A level and the unmethylation index of PDE9A may be useful biomarkers for non-invasive fetal DS detection during the first trimester of pregnancy, regardless of fetal gender.

SUBMITTER: Lim JH 

PROVIDER: S-EPMC3223183 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasma.

Lim Ji Hyae JH   Kim Shin Young SY   Park So Yeon SY   Lee Shin Yeong SY   Kim Mi Jin MJ   Han You Jung YJ   Lee Si Won SW   Chung Jin Hoon JH   Kim Moon Young MY   Yang Jae Hyug JH   Ryu Hyun Mee HM  

PloS one 20111123 11


<h4>Background</h4>Down syndrome (DS) is the most common known aneuploidy, caused by an extra copy of all or part of chromosome 21. Fetal-specific epigenetic markers have been investigated for non-invasive prenatal detection of fetal DS. The phosphodiesterases gene, PDE9A, located on chromosome 21q22.3, is completely methylated in blood (M-PDE9A) and unmethylated in the placenta (U-PDE9A). Therefore, we estimated the accuracy of non-invasive fetal DS detection during the first trimester of pregn  ...[more]

Similar Datasets

| S-EPMC9221829 | biostudies-literature
| S-EPMC3004793 | biostudies-literature
| S-EPMC8362158 | biostudies-literature
| S-EPMC4203771 | biostudies-literature
| S-EPMC3019239 | biostudies-literature
| S-EPMC3362548 | biostudies-literature
| S-EPMC2951898 | biostudies-literature
| S-EPMC7539800 | biostudies-literature
| S-EPMC2597125 | biostudies-literature
| S-EPMC6461288 | biostudies-literature